A couple of months ago I wrote (link here) about how trans women who have undergone SRS still have a prostate gland and are therefore still at risk of developing prostate cancer.
So it’s encouraging to read via the Press Association (link here) and BBC News (link here) that “two men with advanced and inoperable prostate cancer have staged dramatic recoveries after being treated with an experimental antibody drug”.
However, it should be noted that these are only preliminary findings from a small trial and that further larger scale trials and research are needed before concluding that the drug, ipilimumab, really does offer a way to improve on current treatments for advanced prostate cancer.
Finally, I’m still irritated at the way the media and the UK’s own Prostate Cancer Charity persist in erasing the existence of, and risk to, trans women by their continuing insistence that “only men have a prostate gland“. Whilst I have learned to expect only ignorance from the mass media, I would have hoped that “the UK’s leading voluntary organisation working with people affected by prostate cancer” would know better.
Previous, related posts:
- Educating Channel 4 News and the Prostate Cancer Campaign (March 25, 2009)